TX Dallas의 방광암 임상 시험
방광암 관련 연구 27개가 Dallas 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
피험자 모집 중2상
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
피험자 모집 중1상
- Cancer Center Outpatient Building, Dallas
- The University of Texas Southwestern Medical Center, Dallas
- UT Southwestern Medical Center - West Campus Building, Dallas
- 외 2개
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
피험자 모집 중1상
- University of Texas Southwestern, Dallas
- Texas Oncology, P.A, Dallas
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
피험자 모집 중2상
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
피험자 모집 중3상
- Parkland Memorial Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
피험자 모집 중3상
- Parkland Health and Hospital System, Dallas
- UT Southwestern Medical Center, Dallas
Measuring Surgical Recovery After Radical Cystectomy
피험자 모집 중관찰 연구
- University of Texas - Southwestern, Dallas
Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer
피험자 모집 중1/2상
- UT Southwestern Medical Center, Dallas
DESTINY-PANTUMOUR04
피험자 모집 중관찰 연구
- Research Site, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
피험자 모집 중관찰 연구
- UT Southwestern Medical Center, Dallas
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
피험자 모집 중2상
- Urology Clinics of North Texas, PLLC, Dallas
- UT Southwestern Medical Center, Dallas
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
피험자 모집 중관찰 연구
- University of Texas Southwestern Medical Center, Dallas
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
피험자 모집 중2/3상
- Research Site, Dallas
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
피험자 모집 중1/2상
- UT Southwestern Medical Center, Dallas
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
피험자 모집 중2상
- Baylor Scott & White Research Institute, Dallas
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
피험자 모집 중2상
- Baylor Scott and White Research Institute, Dallas
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
피험자 모집 중3상
- Research Site, Dallas
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
피험자 모집 중1상
- NEXT Dallas, Dallas
Predicting BCG Response
피험자 모집 중관찰 연구
- University of Texas Southwestern, Dallas
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
피험자 모집 중
- UT Southwestern Medical Center, Dallas
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
피험자 모집 중관찰 연구
- UT Southwestern Medical Center, Dallas
Bladder Cancer Screening Trial
피험자 모집 중
- University of Texas Southwestern Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- NEXT Oncology - Dallas, Dallas
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
피험자 모집 중1상
- Mary Crowley Cancer Research, Dallas
- Baylor University Medical Center, Dallas
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
피험자 모집 중관찰 연구
- UT Southwestern Medical Center at Dallas, Dallas
Blue Light Cystoscopy With Cysview® Registry
피험자 모집 중관찰 연구
- UT Southwestern, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Dallas
다른 도시의 방광암 시험
- New York City, NY연구 36개
- Nashville, TN연구 31개
- Houston, TX연구 31개
- Boston, MA연구 26개
- Washington, DC연구 26개
- Los Angeles, CA연구 25개
- Baltimore, MD연구 24개
- Philadelphia, PA연구 23개
- Edison, NJ연구 23개
- St. Louis, MO연구 22개
- Chicago, IL연구 21개
- Seattle, WA연구 21개
Dallas의 다른 연구
- 유방암연구 54개
- 비소세포폐암연구 53개
- 전이성 암연구 44개
- 심부전연구 42개
- 암 (전체)연구 40개
- 전립선암연구 39개
- 대장직장암연구 34개
- 비만연구 33개
- 난소암연구 31개
- 폐암연구 26개
- 자궁내막암연구 25개
- 신장암 (신세포암)연구 24개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.